Champions Oncology, Inc

(NASDAQ:CSBR)

Latest On Champions Oncology, Inc (CSBR):

Date/Time Type Description Signal Details
2023-03-17 22:49 ESTNewsChampions Oncology, Inc. (CSBR) Q3 2023 Earnings Call TranscriptN/A
2023-03-16 01:23 ESTNewsChampions Oncology Non-GAAP EPS of -$0.16 misses by $0.15, revenue of $12.77M misses by $0.36MN/A
2023-01-29 10:36 ESTNewsChampions Oncology Trades At A Sufficient Discount To R&D CapacityN/A
2022-12-13 22:00 ESTNewsChampions Oncology Non-GAAP EPS of $0.01 misses by $0.01, revenue of $14.28M beats by $0.34MN/A
2022-12-13 22:00 ESTNewsChampions Oncology, Inc. (CSBR) Q2 2023 Earnings Call TranscriptN/A
2022-09-09 20:30 ESTNewsChampions Oncology, Inc. (CSBR) Q1 2023 Earnings Call TranscriptN/A
2022-09-09 03:14 ESTNewsChampions Oncology GAAP EPS of -$0.02 misses by $0.03, revenue of $13.7M beats by $0.51MN/A
2022-07-22 14:12 ESTNewsChampions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9MN/A
2022-03-17 06:01 ESTNewsChampions Oncology's (CSBR) CEO Ronnie Morris on Q3 2022 Results - Earnings Call TranscriptN/A
2022-03-15 20:57 ESTNewsChampions Oncology Non-GAAP EPS of $0.07, revenue of $13.2MN/A
2022-02-15 22:05 ESTNewsChampions Oncology, GigaMune collaborate on next-gen T cell therapiesN/A
2022-01-20 18:00 ESTNewsChampions Oncology-Fannin team up to develop therapeutics for tumorsN/A
2021-12-14 12:41 ESTNewsChampions Oncology Inc.'s (CSBR) CEO Ronnie Morris on Q2 2022 Results - Earnings Call TranscriptN/A
2021-12-13 17:57 ESTNewsChampions Oncology EPS beats by $0.02, beats on revenueN/A
2021-11-26 14:58 ESTNewsWarning: CSBR is at high risk of performing badlyN/A
2021-09-21 15:35 ESTNewsChampions Oncology EPS in-line, beats on revenueN/A
2021-09-21 15:33 ESTNewsChampions Oncology's (CSBR) CEO Ronnie Morris on Q1 FY2022 Results - Earnings Call TranscriptN/A
2021-03-27 02:03 ESTNewsChampions Oncology (CSBR) Investor Presentation - SlideshowN/A
2021-03-16 20:34 ESTAnalyst RatingThe Analyst Target Price has increased from $13.83 to $15.Buy
2021-03-12 11:25 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 03:28 ESTEarnings EstimateAn EPS average of $0.01 is estimated for the quarter ending on July 31, 2021.Sell
2021-03-12 02:02 ESTNewsChampions Oncology EPS beats by $0.04, beats on revenueN/A
2021-01-20 01:57 ESTNewsChampions Oncology partners with Code Ocean, expanding functionality of Lumin BioinformaticsN/A
2020-12-17 03:29 ESTAnalyst RatingThe Analyst Target Price has increased from $12.83 to $13.83.Buy
2020-12-16 03:35 ESTAnalyst RatingThe Analyst Target Price has increased from $11 to $12.83.Buy
2020-12-15 11:35 ESTFinancialsCompany financials have been released.Neutral
2020-12-14 17:12 ESTNewsChampions Oncology beats on revenueN/A
2020-12-13 03:43 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:31 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 17:04 ESTInsider TradeSCOTT R TOBIN has directly acquired 10,000 shares and currently holds 10,000 shares.Buy
2020-10-30 08:57 ESTInsider TradeDAVID SIDRANSKY has directly acquired 16,667 shares and currently holds 758,334 shares.Buy
2020-09-26 12:27 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 16:54 ESTNewsChampions Oncology +9.8% on FQ1 earnings beatN/A
2020-09-16 08:26 ESTFinancialsCompany financials have been released.Neutral
2020-09-15 12:32 ESTEarnings EstimateAn EPS average of $0.03 is estimated for the quarter ending on January 31, 2021.Buy
2020-09-15 11:55 ESTNewsChampions Oncology EPS beats by $0.01, beats on revenueN/A
2020-09-15 11:55 ESTNewsChampions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2021 Results - Earnings Call TranscriptN/A
2020-09-05 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 12:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 20:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:40 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 20:33 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 12:28 ESTEarnings EstimateAn EPS average of $0.02 is estimated for the quarter ending on October 31, 2020.Buy
2020-07-29 12:28 ESTAnalyst RatingThe Analyst Target Price has increased from $10.33 to $11.Buy
2020-07-28 19:16 ESTNewsChampions Oncology slumps on Q4 reportsN/A
2020-07-28 12:31 ESTEarnings EstimateAn EPS average of $0.30 is estimated for the 2022 year.Buy
2020-07-27 19:41 ESTNewsChampions Oncology EPS misses by $0.18, beats on revenueN/A
2020-07-27 19:40 ESTNewsChampions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q4 2020 Results - Earnings Call TranscriptN/A
2020-07-23 16:43 ESTFinancialsCompany financials have been released.Neutral

About Champions Oncology, Inc (CSBR):

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, the company provides POS products, including TumorGraft implants and drug panels, which utilizes TumorGraft technology to test the response of a patient's tumor to multiple oncology drugs or drug combinations. It markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

CSBR Quotes by TradingView

See Advanced Chart

General

  • Name Champions Oncology, Inc
  • Symbol CSBR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 143
  • Last Split Factor1:12
  • Last Split Date2015-08-12
  • Fiscal Year EndApril
  • IPO Date2003-01-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryLife Sciences Tools & Services
  • Gic SubIndustryLife Sciences Tools & Services
  • Web URLhttp://www.championsoncology.com
View More

Valuation

  • Forward PE 71.43
  • Price/Sales (Trailing 12 Mt.) 4.09
  • Price/Book (Most Recent Quarter) 21.26
  • Enterprise Value Revenue 4.24
  • Enterprise Value EBITDA 481.86
View More

Financials

  • Most Recent Quarter 2021-01-31
  • Current Year EPS Estimate $0.06
  • Next Year EPS Estimate $0.20
  • Profit Margin -3%
  • Operating Margin -2%
  • Return on Assets -2%
  • Return on Equity -22%
  • Revenue 39.22 million
  • Earnings Per Share -$0.09
  • Revenue Per Share $3.06
  • Gross Profit 15.24 million
  • Quarterly Earnings Growth 20%
View More

Highlights

  • Market Capitalization 176.75 million
  • EBITDA 345000
  • Analyst Target Price $15
  • Book Value Per Share $0.59
View More

Share Statistics

  • Shares Outstanding 13.39 million
  • Shares Float 6.55 million
  • % Held by Insiders 2055%
  • % Held by Institutions 53.79%
  • Shares Short 153791
  • Shares Short Prior Month 140204
  • Short Ratio 5.87
  • Short % of Float 3%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.23
  • 52 Week High $14.68
  • 52 Week Low $4.84
  • 50 Day Moving Average 11.69
  • 200 Day Moving Average 10.46
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Champions Oncology, Inc (CSBR) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Champions Oncology, Inc (CSBR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2021-01-312021-03-10$N/A$0.05$0.01400%
2020-10-312020-12-14$N/A$0.00$0.01-98%
2020-07-312020-09-14$9.55 million$0.01$0.010%
2020-04-302020-07-27$N/A-$0.17$0.02-1233.33%
2020-01-312020-03-12$9.01 million$0.03$0.0320%
2019-10-312019-12-16$7.63 million$0.02-$0.03166.67%
2019-07-312019-09-16$6.74 million-$0.06$0.03-300%
2019-04-302019-07-15$7.72 million-$0.02$0.03-166.67%
2019-01-312019-03-18$6.43 million-$0.03$0.02-228.76%
2018-10-312018-12-17$6.69 million$0.02$0.04-50%
2018-07-312018-09-13$6.23 million$0.04$0.01300%
2018-04-302018-07-26$4.92 million-$0.06-$0.04-71.43%
2018-01-312018-03-15$5.08 million-$0.01
2017-10-312017-12-07$5.2 million-$0.01
2017-07-312017-09-14$5.03 million-$0.06
2017-04-302017-07-28$3.72 million-$0.22
2017-01-312017-03-17$3.57 million-$0.13
2016-10-312016-12-14$4.46 million-$0.05
2016-07-312016-09-14$3.67 million-$0.26
2016-04-302016-07-29$2.84 million-$0.30
2016-01-312016-01-31$2.55 million-$0.28
2015-10-312015-10-31$2.97 million-$0.29
2015-07-312015-07-31$2.82 million-$0.33
2015-04-302015-04-30$3.24 million-$0.43
2015-01-312015-01-31$1.83 million-$0.61
2014-10-312014-10-31$1.88 million-$0.65
2014-07-312014-07-31$1.91 million-$0.64
2014-04-302014-04-30$2.46 million-$0.41
2014-01-312014-01-31$3.69 million-$0.10
2013-10-312013-10-31$2.38 million-$0.42
2013-07-312013-07-31$3.02 million-$0.40
2013-04-302013-04-30$1.84 million-$0.47
2013-01-312013-01-31$2.92 million-$0.25
2012-10-312012-10-31$1.46 million-$0.50
2012-07-312012-07-31$2.11 million-$0.34
2012-04-302012-04-30$1.38 million-$0.65
2012-01-312012-01-31$2.4 million-$0.44
2011-10-312011-10-31$1.74 million-$0.60
2011-07-312011-07-31$1.63 million-$0.53
2011-04-302011-04-30$1.54 million-$0.90
2011-01-312011-02-15$2.81 million-$0.14
2010-10-312010-11-15$933000-$0.02
2010-07-312010-08-15$1.6 million-$0.20
2010-04-302010-05-15$1.9 million-$0.20
2010-01-312010-02-15$742000-$0.28
2009-10-312009-11-15$1.29 million-$0.21
2009-07-312009-08-15$962000-$0.37
2009-04-302009-05-15$1.01 million-$0.48
2009-01-312009-01-31$983000-$0.22
2008-10-312008-10-31$1.04 million-$0.08
2008-07-312008-07-31$673000-$0.05
2008-04-302008-04-30$525000-$0.11
2008-01-312008-01-31$625000$0.11
2007-10-312007-10-31$-250000-$0.06
2007-07-312007-07-31$250000$0.00
2007-04-302007-05-15$N/A-$0.06
2007-01-312007-02-15$N/A-$0.02
2006-10-312006-11-15$N/A-$0.03
2006-07-312006-08-15$N/A-$0.01
2006-04-302006-05-15$N/A$0.00
2006-01-312006-02-15$N/A$0.02
2005-10-312005-11-15$N/A-$0.03
2005-07-312005-08-15$N/A-$0.17
2005-04-302005-04-30$1.79 million$0.01
2005-01-312005-01-31$N/A-$0.06
2004-10-312004-10-31$N/A-$0.02
2004-07-312004-08-15$N/A-$0.04
2004-04-302004-05-15$538000$0.01
2002-10-312002-10-31$551000$0.03
2000-01-312000-01-31$474000$0.05
1999-01-311999-01-31$0.07

Champions Oncology, Inc (CSBR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Champions Oncology, Inc (CSBR) Chart:

Champions Oncology, Inc (CSBR) News:

Below you will find a list of latest news for Champions Oncology, Inc (CSBR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Champions Oncology, Inc (CSBR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 00TRUE00
2024-05-1751.1CALL0 50TRUE00
2024-05-177.50.4CALL0 250FALSE00
2024-05-17100CALL0 00FALSE00
2024-05-1712.50.25CALL0 300FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.2PUT0 2190FALSE00
2024-05-177.51.9PUT0 380TRUE00
2024-05-17104.4PUT0 00TRUE00
2024-05-1712.50PUT0 00TRUE00
2024-08-162.50CALL0 00TRUE00
2024-08-1651.25CALL0 90TRUE00
2024-08-167.51CALL0 150FALSE00
2024-08-162.50.45PUT0 40FALSE00
2024-08-1651.45PUT0 60FALSE00
2024-08-167.51.9PUT0 1750TRUE00
2024-11-152.50CALL0 00TRUE00
2024-11-1551.65CALL0 40TRUE00
2024-11-157.50CALL0 00FALSE00
2024-11-15100CALL0 00FALSE00
2024-11-152.50PUT0 00FALSE00
2024-11-1551.5PUT0 50FALSE00
2024-11-157.50PUT0 00TRUE00
2024-11-15100PUT0 00TRUE00

Latest CSBR Trades:

Date Shares Price
Jun 13, 2022 4:07 PM EST100$7.3
Jun 13, 2022 4:08 PM EST100$7.31
Jun 13, 2022 4:08 PM EST100$7.3

Champions Oncology, Inc (CSBR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020004386/0001628280-20-004386-index.htm
2017-01-13SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/771856/000114036117001769/0001140361-17-001769-index.htm
2017-08-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/771856/000114036117030547/0001140361-17-030547-index.htm
2016-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000114420416131340/0001144204-16-131340-index.htm
2016-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000114420416131342/0001144204-16-131342-index.htm
2019-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000117911019005296/0001179110-19-005296-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000117911020003543/0001179110-20-003543-index.htm
2020-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000117911020010718/0001179110-20-010718-index.htm
2016-10-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/771856/000119312516751759/0001193125-16-751759-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000120919120017699/0001209191-20-017699-index.htm
2016-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828016020505/0001628280-16-020505-index.htm
2016-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828016020507/0001628280-16-020507-index.htm
2016-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828016020509/0001628280-16-020509-index.htm
2016-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828016020689/0001628280-16-020689-index.htm
2016-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828016020690/0001628280-16-020690-index.htm
2016-11-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828016021506/0001628280-16-021506-index.htm
2016-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828016021508/0001628280-16-021508-index.htm
2016-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828016021707/0001628280-16-021707-index.htm
2016-12-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828016022031/0001628280-16-022031-index.htm
2017-01-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017000428/0001628280-17-000428-index.htm
2017-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828017002464/0001628280-17-002464-index.htm
2017-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017002637/0001628280-17-002637-index.htm
2017-03-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828017002681/0001628280-17-002681-index.htm
2017-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017004475/0001628280-17-004475-index.htm
2017-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017005232/0001628280-17-005232-index.htm
2017-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017007345/0001628280-17-007345-index.htm
2017-07-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/771856/000162828017007429/0001628280-17-007429-index.htm
2017-08-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/771856/000162828017008952/0001628280-17-008952-index.htm
2017-08-31DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/771856/000162828017009028/0001628280-17-009028-index.htm
2017-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017009310/0001628280-17-009310-index.htm
2017-09-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828017009317/0001628280-17-009317-index.htm
2017-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017009685/0001628280-17-009685-index.htm
2017-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017009909/0001628280-17-009909-index.htm
2017-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828017011455/0001628280-17-011455-index.htm
2017-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828017011460/0001628280-17-011460-index.htm
2017-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828017011463/0001628280-17-011463-index.htm
2017-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828017011470/0001628280-17-011470-index.htm
2017-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828017012191/0001628280-17-012191-index.htm
2017-12-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828017012357/0001628280-17-012357-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828018003075/0001628280-18-003075-index.htm
2018-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828018003224/0001628280-18-003224-index.htm
2018-03-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828018003346/0001628280-18-003346-index.htm
2018-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018003566/0001628280-18-003566-index.htm
2018-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018003737/0001628280-18-003737-index.htm
2018-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828018009635/0001628280-18-009635-index.htm
2018-07-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/771856/000162828018009773/0001628280-18-009773-index.htm
2018-08-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/771856/000162828018011478/0001628280-18-011478-index.htm
2018-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828018011830/0001628280-18-011830-index.htm
2018-09-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828018011874/0001628280-18-011874-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018012240/0001628280-18-012240-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018012338/0001628280-18-012338-index.htm
2018-10-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018012512/0001628280-18-012512-index.htm
2018-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018012548/0001628280-18-012548-index.htm
2018-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828018012569/0001628280-18-012569-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018013555/0001628280-18-013555-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018013556/0001628280-18-013556-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018013557/0001628280-18-013557-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018013558/0001628280-18-013558-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018013559/0001628280-18-013559-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018013560/0001628280-18-013560-index.htm
2018-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018014013/0001628280-18-014013-index.htm
2018-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828018015177/0001628280-18-015177-index.htm
2018-12-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828018015187/0001628280-18-015187-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828018015324/0001628280-18-015324-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019000100/0001628280-19-000100-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019000136/0001628280-19-000136-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019000359/0001628280-19-000359-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019003074/0001628280-19-003074-index.htm
2019-03-1810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828019003086/0001628280-19-003086-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019008752/0001628280-19-008752-index.htm
2019-07-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/771856/000162828019009139/0001628280-19-009139-index.htm
2019-08-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/771856/000162828019011252/0001628280-19-011252-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019011423/0001628280-19-011423-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019011740/0001628280-19-011740-index.htm
2019-09-1610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828019011753/0001628280-19-011753-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019012310/0001628280-19-012310-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019013526/0001628280-19-013526-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019013528/0001628280-19-013528-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019013530/0001628280-19-013530-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019013531/0001628280-19-013531-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019013532/0001628280-19-013532-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019013533/0001628280-19-013533-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828019014734/0001628280-19-014734-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828019015102/0001628280-19-015102-index.htm
2019-12-1610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828019015106/0001628280-19-015106-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020000084/0001628280-20-000084-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020003461/0001628280-20-003461-index.htm
2020-03-1610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828020003637/0001628280-20-003637-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020003966/0001628280-20-003966-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020004085/0001628280-20-004085-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020004087/0001628280-20-004087-index.htm
2020-03-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020004374/0001628280-20-004374-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020004386/0001628280-20-004386-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020010661/0001628280-20-010661-index.htm
2020-07-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/771856/000162828020010734/0001628280-20-010734-index.htm
2020-08-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/771856/000162828020013113/0001628280-20-013113-index.htm
2020-09-11DEFM14ADefinitive proxy statement relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/771856/000162828020013464/0001628280-20-013464-index.htm
2020-09-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/771856/000162828020013466/0001628280-20-013466-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020013549/0001628280-20-013549-index.htm
2020-09-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/771856/000162828020013559/0001628280-20-013559-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020014503/0001628280-20-014503-index.htm
2020-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/771856/000162828020014644/0001628280-20-014644-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020014963/0001628280-20-014963-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020015394/0001628280-20-015394-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020015396/0001628280-20-015396-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020015400/0001628280-20-015400-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/771856/000162828020015402/0001628280-20-015402-index.htm
2016-12-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/771856/000168316816000921/0001683168-16-000921-index.htm
2018-08-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/771856/000168316818002160/0001683168-18-002160-index.htm

Champions Oncology, Inc (CSBR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Champions Oncology, Inc (CSBR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2055%
Institutional Ownership: 5379%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-30SCOTT R TOBINDirectorBuy10,000.005.4654,600.0010,000.00https://www.sec.gov/Archives/edgar/data/771856/000117911020010718/0001179110-20-010718-index.htm
2018-10-01JOEL ACKERMANDirectorSell22,535.0017.02383,545.701,021,731.00https://www.sec.gov/Archives/edgar/data/771856/000162828018012240/0001628280-18-012240-index.htm
2018-03-22Ronnie MorrisCEOBuy60.003.50210.001,111,407.00https://www.sec.gov/Archives/edgar/data/771856/000162828018003566/0001628280-18-003566-index.htm
2018-03-23Ronnie MorrisCEOBuy440.003.501,540.001,111,847.00https://www.sec.gov/Archives/edgar/data/771856/000162828018003566/0001628280-18-003566-index.htm
2018-03-22Ronnie MorrisCEOBuy200.003.48696.501,112,047.00https://www.sec.gov/Archives/edgar/data/771856/000162828018003566/0001628280-18-003566-index.htm
2019-01-02JOEL ACKERMANDirectorBuy4,167.004.8020,001.601,113,877.00https://www.sec.gov/Archives/edgar/data/771856/000162828019000100/0001628280-19-000100-index.htm
2018-03-26Ronnie MorrisCEOBuy2,235.003.577,978.951,114,282.00https://www.sec.gov/Archives/edgar/data/771856/000162828018003737/0001628280-18-003737-index.htm
2018-03-27Ronnie MorrisCEOBuy2,300.003.628,319.101,116,582.00https://www.sec.gov/Archives/edgar/data/771856/000162828018003737/0001628280-18-003737-index.htm
2018-10-12JOEL ACKERMANDirectorBuy100,000.002.10210,000.001,121,731.00https://www.sec.gov/Archives/edgar/data/771856/000162828018012512/0001628280-18-012512-index.htm
2019-12-02JOEL ACKERMANDirectorBuy201,590.002.10423,339.001,315,467.00https://www.sec.gov/Archives/edgar/data/771856/000162828019014734/0001628280-19-014734-index.htm
2019-12-02JOEL ACKERMANDirectorBuy1,521.002.103,194.101,316,988.00https://www.sec.gov/Archives/edgar/data/771856/000162828019014734/0001628280-19-014734-index.htm
2020-03-06New Enterprise Associates 14, L.P.10% Share HolderSell708,155.006.994,950,003.451,713,720.00https://www.sec.gov/Archives/edgar/data/771856/000120919120017699/0001209191-20-017699-index.htm
2018-11-06Daniel Newman MendelsonDirectorSell5,000.0013.7568,750.0057,500.00https://www.sec.gov/Archives/edgar/data/771856/000162828018014013/0001628280-18-014013-index.htm
2020-03-24Daniel Newman MendelsonDirectorBuy26.005.50143.0057,526.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004087/0001628280-20-004087-index.htm
2020-03-26Daniel Newman MendelsonDirectorBuy20.006.00120.0057,546.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/0001628280-20-004374-index.htm
2020-03-26Daniel Newman MendelsonDirectorBuy100.005.99599.0057,646.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/0001628280-20-004374-index.htm
2020-03-26Daniel Newman MendelsonDirectorBuy100.005.97597.0057,746.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/0001628280-20-004374-index.htm
2020-03-26Daniel Newman MendelsonDirectorBuy700.005.904,130.0058,446.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/0001628280-20-004374-index.htm
2020-03-26Daniel Newman MendelsonDirectorBuy300.005.891,767.0058,746.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/0001628280-20-004374-index.htm
2018-09-20Daniel Newman MendelsonDirectorSell8,333.0013.02108,495.6662,500.00https://www.sec.gov/Archives/edgar/data/771856/000162828018012338/0001628280-18-012338-index.htm
2020-10-16DAVID SIDRANSKYDirectorBuy16,667.005.4691,001.82758,334.00https://www.sec.gov/Archives/edgar/data/771856/000162828020014963/0001628280-20-014963-index.htm
2018-12-19Ronnie MorrisCEOBuy20,000.007.44148,800.00833,001.00https://www.sec.gov/Archives/edgar/data/771856/000162828018015324/0001628280-18-015324-index.htm
2019-01-16Ronnie MorrisCEOBuy4,167.004.8020,001.60837,168.00https://www.sec.gov/Archives/edgar/data/771856/000162828019000359/0001628280-19-000359-index.htm
2020-03-24Ronnie MorrisCEOSell75.005.25393.75837,168.00https://www.sec.gov/Archives/edgar/data/771856/000162828020004085/0001628280-20-004085-index.htm